Navigation Links
New Post Hoc Analyses Examined the Effects of Neupro® (Rotigotine Transdermal System) on Daytime Functioning, Daytime Symptoms, Pain and Mood in Restless Legs Syndrome
Date:6/10/2011

resulted in accidents. Some patients perceived no warning signs, such as excessive drowsiness. Hallucinations were reported in 2.0% of patients treated with Neupro® compared to 0.7% of patients on placebo. Neupro® contains metabisulfite. Neupro® should be used with caution in patients, especially those at risk for cardiovascular disease, because of the potential for symptomatic hypotension, syncope, elevated heart rate, elevated blood pressure, fluid retention, and/or weight gain. All Parkinson's disease patients are at a higher risk for melanoma and should be monitored regularly. The most commonly reported side effects in clinical trials were nausea, application site reactions, somnolence, dizziness, headache, vomiting, and insomnia. Some subjects who received Neupro® experienced a decline in blood hemoglobin levels (about 2% relative to subjects who received placebo). It is not known whether this change is readily reversible with discontinuation of Neupro®.  Please go to http://www.neupro.com/documents/Neupro_PI_071207.pdf for US Full Prescribing Information. 

Neupro® is a registered trademark of the UCB Group of companies.

About rotigotine transdermal in Canada

Rotigotine transdermal is not authorized for sale in Canada.

For further information

Nancy Nackaerts, External Communications, UCB
T +32.473.864.414, nancy.nackaerts@ucb.com

Eimear O'Brien, Associate Director, Global CNS Communications UCB
T +32.2.559.9271, eimear.obrien@ubc.com

Andrea Levin, Senior Manager, Communications & PR, U.S.
T +770.970.8352, andrea.levin@ucb.com

About UCB<
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Four Analyses of Three-Year Clinical Data Suggest CYPHER(R) Sirolimus-Eluting Coronary Stent May Provide Alternative to Surgery for Patients with Multivessel Disease
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
5. New Analyses of Long-Term LIALDA(TM) (mesalamine) Data Presented at ACG
6. New MIRCERA(R) Data Analyses to be Featured at the American Society of Nephrology Annual Meeting
7. New Analyses Presented at ASCO Reaffirmed Efficacy and Safety of TORISEL in Patients With Advanced Kidney Cancer
8. Preliminary Analyses from Phase 2 Genzyme Study Highlight Efficacy and Safety of Clofarabine in Older Adult AML Patients
9. Independent Analyses of the SEAS, SHARP and IMPROVE-IT Studies of Ezetimibe
10. New Analyses Indicate that Divigel(R) (estradiol gel) 0.1% Is a Valuable Option for Certain Postmenopausal Women With Hot Flashes
11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... Quebec, July 31, 2014   , 2014 Second ... the prior year , Overall organic growth was 4% for ... injectable products; Bausch + Lomb grew 12% , 2014 ... of 43% , 2014 Second Quarter GAAP Operating Cash ... , Highlights of the Second Quarter , Launched 17 ...
(Date:7/31/2014)... 2014 Auxilium Pharmaceuticals, Inc. ... company, today announced that the Company will receive ... partner Asahi Kasei Pharma Corporation (Asahi Kasei). The ... of a regulatory application to the Japanese Pharmaceutical ... (collagenase clostridium histolyticum) for the treatment of ...
(Date:7/31/2014)... 2014 MarketResearchreports.biz presents this most ... (Rapid-Acting, Short-Acting, Intermediate-Acting, Long-Acting, Premixed, And Modern and ... and Forecast (Value and Volume), 2013 - 2019: Market ... growing at an exponential rate worldwide, has become a ... major cause of death of people between 20 years ...
Breaking Medicine Technology:Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 2Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 3Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 4Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 5Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 6Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 7Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 8Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 9Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 10Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 11Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 12Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 13Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 14Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 15Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 16Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 17Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 18Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 19Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 20Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 21Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 22Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 23Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 24Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 25Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 26Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 27Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 28Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 29Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 30Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 31Valeant Pharmaceuticals Reports Second Quarter 2014 Financial Results 32Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5
... First Pro-Healing Stent Also ... Featured at Annual Symposium, ... the subject of several sessions about,innovation in interventional cardiology strategies ... 2007,which is set for Oct. 20-25 at the Washington Convention ...
... Bono Initiative Aims to Mobilize $25 Million to Eliminate ... Afflicting the Poorest of the Poor, EAST RUTHERFORD, N.J., ... nation,s top ten public relations firms, was,highlighted by President Bill ... for its key role in the fight against diseases of,poverty ...
Cached Medicine Technology:OrbusNeich's Genous(TM) Bio-Engineered R Stent(TM) is Subject of Sessions on Innovation at TCT 2007 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 2President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 3President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its 'Stop Neglected Tropical Disease' Campaign 4
(Date:7/31/2014)... Controlled application of vacuum pressure is a promising approach ... suggests an experimental study in the August issue of ... Congress of Neurological Surgeons . The journal is ... part of Wolters Kluwer Health . , ... injured area of the brainshows promise as a safe ...
(Date:7/31/2014)... and Las Vegas, Nevada (PRWEB) July 31, 2014 ... LaunchKey to provide next generation authentication services to cloud ... secure way to utilize hardware protected multi-factor authentication with ... in the Internet's reliance on password-based authentication. It is ... global data breaches taking place around the globe. Instead ...
(Date:7/31/2014)... Texas (PRWEB) July 31, 2014 The ... Patient Experience Executive Board and four new members ... strengthening its role as the global community of practice ... in healthcare. , Executive board members are industry ... plans, and provide valuable insight into market and industry ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 Web Programming ... ISO 9001:2008 certified internet marketing firm, has recently launched ... to make this service affordable for everyone, the company ... the service. , Web Programming Services has tailored ... world of brochure designing and likely expectations of the ...
(Date:7/31/2014)... Steven Reinberg HealthDay Reporter ... Strict regulation of electronic cigarettes isn,t warranted based on ... the contrary, allowing e-cigarettes to compete with regular cigarettes ... after reviewing 81 prior studies on the use and ... evidence suggests that there is a potential for smokers ...
Breaking Medicine News(10 mins):Health News:Vacuum treatment may limit damage after traumatic brain injury 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 2Health News:Rivetz Partners with LaunchKey to Offer Next Generation Authentication for Accounts Leveraging Trusted Execution Technology. 3Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 2Health News:The Beryl Institute Announces Seven New Patient Experience Board Members 3Health News:Web Programming Services Introduces Affordable Brochure Designing Service 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 2Health News:Benefits of E-Cigarettes May Outweigh Harms, Study Finds 3
... trigger urge to smoke, researchers say , WEDNESDAY, Sept. 9 ... component in cigarettes, "tricks" the brain into creating memory associations ... why former smokers miss lighting up when they are in ... from researchers at Baylor College of Medicine are in the ...
... response , WEDNESDAY, Sept. 9 (HealthDay News) -- Early day ... and illnesses at an early age, thereby protecting them from ... the ,hygiene hypothesis," but a new study casts doubt on ... asthma and allergy rates at age 8. , An unexplained ...
... , SOUTHFIELD, Mich., Sept. 9 The Wild ... employee health screenings. While national and local regulations cover finger sticks ... national standards and monitors on-site health screenings or flu shot programs. ... approaches, a new white paper from wellness screening provider Summit Health, ...
... PRINCETON, N.J., Sept. 9 From October 5-9, contact center ... Mandalay Bay Convention Center to attend the sixth annual 2009 ... Produced by the International Customer Management Institute (ICMI), this year,s ... the Customer Experience." Intensive, daylong pre-conference summits for financial services ...
... , CHICAGO, Sept. 9 Morrisey ... high-risk, complex patients outside the acute-care setting. , ... (MCCM(TM)) Continuum of Care software enables organizations to extend their ... are able to reduce unnecessary hospital admissions, emergency department visits ...
... , , , SHREVEPORT, La., ... set out on her life-finding mission with a book contract in her pocket. ... giant in Italy, she was just living. She had no notion that what ... , But life took this Louisiana-raised girl and her endearing ...
Cached Medicine News:Health News:Nicotine Plays Tricks on Brain: Study 2Health News:Day Care May Not Shield Kids From Asthma, Allergies 2Health News:Day Care May Not Shield Kids From Asthma, Allergies 3Health News:Summit Health Helps Employers Navigate the 'Wild West' of Flu Shots and Workplace Health Screenings 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 2Health News:Global Gathering for Contact Center Professionals to Focus On 'Thinking Forward - The Power of the Customer Experience' at ICMI's Annual Call Center Exhibition Conference and Expo, Oct. 5-9 in Las Vegas 3Health News:Morrisey Associates Helps Healthcare Organizations Improve Patient Management Outside the Acute-Care Setting 2Health News:Exotic Adventure and Clean Food: The Adventure Cookbook 2
... 2000 Pipette is a synonym for pipetting ... robust design, and superior operating comfort. Its ... the measuring stroke and blow-out as well ... system ensures utmost accuracy and precision. Ejection ...
... Remels newest member of the Xpect family, Xpect ... and B in one rapid test. The simple-to-perform ... available in 20 minutes. ,The Remel Xpect family ... range of rapid, direct specimen tests that combine ...
Inquire...
Inquire...
Medicine Products: